63263 Neu-Isenburg, de
Carl Johan Corneliussen
+45 (3266) 2926
Strong fourth quarter triggers earnings upgrade
Furthermore, we have experienced an attractive product mix and strong plant utilisation, and we therefore expect EBIT* of at least DKK 1,700 million. This corresponds to an earnings upgrade of over DKK 100 million compared to our previous outlook and reflects an EBIT margin (before Bio Chemical Projects) of at least 12.8%.
The momentum in profitability means that we have already met our financial milestone of 12.5% in EBIT margin (before Bio Chemicals Projects) in FY 2009/10.
We will release our full annual report for 2009/10, including management outlook for the coming financial year, on 22 June 2010.
* In this release, EBIT refers to EBIT before special items and sharebased payments unless otherwise stated
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.